Cantó, E.; Faba, Ó.R.; Zamora, C.; Mulet, M.; Garcia-Cuerva, M.S.; Palomino, A.; Anguera, G.; Breda, A.; Maroto, P.; Vidal, S.
Immunological Status of Bladder Cancer Patients Based on Urine Leukocyte Composition at Radical Cystectomy. Biomedicines 2021, 9, 1125.
https://doi.org/10.3390/biomedicines9091125
AMA Style
Cantó E, Faba ÓR, Zamora C, Mulet M, Garcia-Cuerva MS, Palomino A, Anguera G, Breda A, Maroto P, Vidal S.
Immunological Status of Bladder Cancer Patients Based on Urine Leukocyte Composition at Radical Cystectomy. Biomedicines. 2021; 9(9):1125.
https://doi.org/10.3390/biomedicines9091125
Chicago/Turabian Style
Cantó, Elisabet, Óscar Rodríguez Faba, Carlos Zamora, Maria Mulet, Maria Soledad Garcia-Cuerva, Ana Palomino, Georgia Anguera, Alberto Breda, Pablo Maroto, and Sílvia Vidal.
2021. "Immunological Status of Bladder Cancer Patients Based on Urine Leukocyte Composition at Radical Cystectomy" Biomedicines 9, no. 9: 1125.
https://doi.org/10.3390/biomedicines9091125
APA Style
Cantó, E., Faba, Ó. R., Zamora, C., Mulet, M., Garcia-Cuerva, M. S., Palomino, A., Anguera, G., Breda, A., Maroto, P., & Vidal, S.
(2021). Immunological Status of Bladder Cancer Patients Based on Urine Leukocyte Composition at Radical Cystectomy. Biomedicines, 9(9), 1125.
https://doi.org/10.3390/biomedicines9091125